Depression, so Biomarkers Can Guide the Choice of Medications
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
A study published in Nature Mental Health found that patients with favorable biological profiles had stronger responses to common antidepressants, although researchers warn that technology is not yet ready for routine clinical use. The post UC Irvine tests biomarkers to customize treatments against depression appeared first on Hispanics Press.
AGI - Using biological and behavioral biomarkers to choose from the beginning the most suitable antidepressant drug could increase by almost 67% the probability of response to therapy compared to patients who do not have favorable biological profiles. It is the result of a study coordinated by Diego A. Pizzagalli, University of California, Irvine, in collaboration with McLean Hospital-Mass General Brigham, published in the magazine Nature Mental…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
